186 related articles for article (PubMed ID: 24299154)
1. Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation.
Meads C; Davenport C; Małysiak S; Kowalska M; Zapalska A; Guest P; Martin-Hirsch P; Borowiack E; Auguste P; Barton P; Roberts T; Khan K; Sundar S
BJOG; 2014 Mar; 121(4):398-407. PubMed ID: 24299154
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
4. Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.
Auguste P; Barton P; Meads C; Davenport C; Małysiak S; Kowalska M; Zapalska A; Guest P; Martin-Hirsch P; Borowiack E; Khan K; Sundar S; Roberts T
BJOG; 2014 Mar; 121(4):464-76. PubMed ID: 24299112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.
Shao H; Ma X; Gao Y; Wang J; Wu J; Wang B; Li J; Tian J
Medicine (Baltimore); 2018 Nov; 97(48):e12900. PubMed ID: 30508883
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.
Chu Y; Zheng A; Wang F; Lin W; Yang X; Han L; Chen Y; Bai L
Nucl Med Commun; 2014 Feb; 35(2):144-50. PubMed ID: 24177043
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
[TBL] [Abstract][Full Text] [Related]
8. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis.
Ding XP; Feng L; Ma L
Arch Gynecol Obstet; 2014 Oct; 290(4):741-7. PubMed ID: 24798933
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Goense L; van Rossum PS; Reitsma JB; Lam MG; Meijer GJ; van Vulpen M; Ruurda JP; van Hillegersberg R
J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Wei J; Pei S; Zhu X
Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
[TBL] [Abstract][Full Text] [Related]
12. FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI.
Stojiljkovic M; Sobic Saranovic D; Odalovic S; Popovic M; Petrovic J; Rankovic N; Veljkovic M; Artiko V
Radiol Oncol; 2022 Dec; 56(4):453-460. PubMed ID: 36317553
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET for management of cervical and ovarian cancer.
Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.
Woo S; Atun R; Ward ZJ; Scott AM; Hricak H; Vargas HA
Eur Radiol; 2020 Oct; 30(10):5560-5577. PubMed ID: 32415584
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.
Sanei Sistani S; Parooie F; Salarzaei M
Contrast Media Mol Imaging; 2021; 2021():8874990. PubMed ID: 33746650
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Chung HH; Jo H; Kang WJ; Kim JW; Park NH; Song YS; Chung JK; Kang SB; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):529-34. PubMed ID: 17049971
[TBL] [Abstract][Full Text] [Related]
17. Imaging tests for the detection of osteomyelitis: a systematic review.
Llewellyn A; Jones-Diette J; Kraft J; Holton C; Harden M; Simmonds M
Health Technol Assess; 2019 Oct; 23(61):1-128. PubMed ID: 31670644
[TBL] [Abstract][Full Text] [Related]
18. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis.
Choi HJ; Ju W; Myung SK; Kim Y
Cancer Sci; 2010 Jun; 101(6):1471-9. PubMed ID: 20298252
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.
Pan L; Han Y; Sun X; Liu J; Gang H
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1007-22. PubMed ID: 20091186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
